144 related articles for article (PubMed ID: 10073873)
1. Long-term outcome in patients with chronic atrial fibrillation after successful internal cardioversion.
Tse HF; Lau CP; Ayers GM
Am J Cardiol; 1999 Feb; 83(4):607-9, A8, A10. PubMed ID: 10073873
[TBL] [Abstract][Full Text] [Related]
2. Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial.
Singh SN; Tang XC; Reda D; Singh BN
Heart Rhythm; 2009 Feb; 6(2):152-5. PubMed ID: 19187902
[TBL] [Abstract][Full Text] [Related]
3. Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters.
Biffi M; Boriani G; Bartolotti M; Bacchi Reggiani L; Zannoli R; Branzi A
Heart; 2002 May; 87(5):443-8. PubMed ID: 11997417
[TBL] [Abstract][Full Text] [Related]
4. Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries.
Wong CK; White HD; Wilcox RG; Criger DA; Califf RM; Topol EJ; Ohman EM;
Heart; 2002 Oct; 88(4):357-62. PubMed ID: 12231591
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned.
Vijayalakshmi K; Whittaker VJ; Sutton A; Campbell P; Wright RA; Hall JA; Harcombe AA; Linker NJ; Stewart MJ; Davies A; de Belder MA
Am Heart J; 2006 Apr; 151(4):863.e1-6. PubMed ID: 16569550
[TBL] [Abstract][Full Text] [Related]
6. [Role amiodarone in sinus rhythm maintenance after successful cardioversion in patients with chronic non-valvular atrial fibrillation].
Kosior D; Szulc M; Zawadzka M; Pierścińska M; Stawicki S; Rabczenko D; Torbicki A; Opolski G
Pol Arch Med Wewn; 2002 Dec; 108(6):1151-60. PubMed ID: 12687927
[TBL] [Abstract][Full Text] [Related]
7. Exercise capacity in atrial fibrillation: a substudy of the Sotalol-Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T).
Atwood JE; Myers JN; Tang XC; Reda DJ; Singh SN; Singh BN
Am Heart J; 2007 Apr; 153(4):566-72. PubMed ID: 17383295
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of sequential antiarrhythmic treatment in sinus rhythm maintenance after successful electrocardioversion in patients with chronic non-valvular atrial fibrillation.
Kosior D; Opolski G; Torbicki A
Med Sci Monit; 2001; 7(1):68-73. PubMed ID: 11208496
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic reversion of persistent atrial fibrillation with amiodarone predicts long-term sinus rhythm maintenance.
Galperín J; Elizari MV; Chiale PA; Molina RT; Ledesma R; Scapín AO; Blanco MV; Bonato R; Lago M;
J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):179-86. PubMed ID: 14506542
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing long term persistence of sinus rhythm after a first electrical cardioversion for atrial fibrillation.
Duytschaever M; Haerynck F; Tavernier R; Jordaens L
Pacing Clin Electrophysiol; 1998 Jan; 21(1 Pt 2):284-7. PubMed ID: 9474689
[TBL] [Abstract][Full Text] [Related]
11. Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct-current cardioversion.
Opolski G; Stanisławska J; Górecki A; Swiecicka G; Torbicki A; Kraska T
Clin Cardiol; 1997 Apr; 20(4):337-40. PubMed ID: 9098591
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of atrial fibrillation in a Hungarian hospital department of cardiologic internal medicine at the turn of the millennium].
Márk L; Erdej F; Dani G; Borbély M; Sziklai G; Nagy E; Hajdara I; Katona A
Orv Hetil; 2004 May; 145(19):1001-6. PubMed ID: 15181735
[TBL] [Abstract][Full Text] [Related]
13. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation.
Capucci A; Villani GQ; Aschieri D; Rosi A; Piepoli MF
Eur Heart J; 2000 Jan; 21(1):66-73. PubMed ID: 10610746
[TBL] [Abstract][Full Text] [Related]
14. Atrial fibrillation: rate control often better than rhythm control.
Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
[TBL] [Abstract][Full Text] [Related]
15. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
Joseph AP; Ward MR
Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228
[TBL] [Abstract][Full Text] [Related]
16. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
Frick M; Darpö B; Ostergren J; Rosenqvist M
Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of amiodarone for preventing the recurrence of symptomatic paroxysmal and persistent atrial fibrillation after cardioversion.
Komatsu T; Tachibana H; Sato Y; Ozawa M; Nakamura M; Okumura K
Circ J; 2007 Jan; 71(1):46-51. PubMed ID: 17186977
[TBL] [Abstract][Full Text] [Related]
18. Clinical predictors and time course of arrhythmia recurrence in patients with early reinitiation of atrial fibrillation after successful internal cardioversion.
Tse HF; Lau CP
Pacing Clin Electrophysiol; 2003 Sep; 26(9):1809-14. PubMed ID: 12930494
[TBL] [Abstract][Full Text] [Related]
19. A randomized comparison of external and internal cardioversion of chronic atrial fibrillation.
Lévy S; Lauribe P; Dolla E; Kou W; Kadish A; Calkins H; Pagannelli F; Moyal C; Bremondy M; Schork A
Circulation; 1992 Nov; 86(5):1415-20. PubMed ID: 1423954
[TBL] [Abstract][Full Text] [Related]
20. Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods.
Naegeli B; Straumann E; Bertel O
Int J Cardiol; 2005 Mar; 99(2):283-7. PubMed ID: 15749188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
